3-aminophenoxazone has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y; Machihara, K; Murakami, I; Namba, T; Tanaka, H | 1 |
| Che, XF; Miyazawa, K; Moriya, S; Tabuchi, T; Takemura, A; Tomoda, A | 1 |
2 other study(ies) available for 3-aminophenoxazone and Experimental Hepatoma
| Article | Year |
|---|---|
Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Niacinamide; Oxazines; Phenylurea Compounds; Sorafenib; Structure-Activity Relationship | 2017 |
Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line R
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Oxazines; Rats | 2012 |